Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Travelers Companies
TRV
$77.4B
| $7.87M | 0.14% |
57,451
+38,407
| +202% | +$5.23M |
|
202
VF Corp
VFC
$5.6B
| $7.84M | 0.14% |
78,722
-213,501
| -73% | -$19.1M |
|
203
Norwegian Cruise Line
NCLH
$7.84B
| $7.78M | 0.14% |
133,198
-12,374
| -9% | -$653K |
|
|
WRK
204
DELISTED
WestRock Company
WRK
| $7.7M | 0.14% |
179,524
+50,615
| +39% | +$1.97M |
|
205
Parker-Hannifin
PH
$127B
| $7.68M | 0.14% |
37,311
-67,696
| -64% | -$13.1M |
|
206
Cencora
COR
$61.7B
| $7.6M | 0.14% |
89,421
-140,143
| -61% | -$12M |
|
207
Hubbell
HUBB
$24.7B
| $7.55M | 0.14% |
51,087
-19,658
| -28% | -$2.8M |
|
208
Citigroup
C
$221B
| $7.55M | 0.14% |
94,500
-7,168
| -7% | -$530K |
|
209
Regal Rexnord
RRX
$10.7B
| $7.43M | 0.14% |
86,793
+706
| +0.8% | +$56K |
|
210
Bio-Rad Laboratories Class A
BIO
$10B
| $7.41M | 0.14% |
20,017
+1,498
| +8% | +$528K |
|
211
NetApp
NTAP
$36.9B
| $7.38M | 0.14% |
118,510
-138,355
| -54% | -$8.07M |
|
212
Magna International
MGA
$18.3B
| $7.33M | 0.13% |
133,576
+7,325
| +6% | +$397K |
|
213
Arista Networks
ANET
$238B
| $7.28M | 0.13% |
572,320
+481,344
| +529% | +$6.33M |
|
|
NUAN
214
DELISTED
Nuance Communications, Inc.
NUAN
| $7.28M | 0.13% |
408,008
-248,678
| -38% | -$4.12M |
|
215
NovoCure
NVCR
$1.96B
| $7.27M | 0.13% |
86,272
-4,539
| -5% | -$366K |
|
216
Mattel
MAT
$4.19B
| $7.26M | 0.13% |
536,040
-171,766
| -24% | -$2.04M |
|
217
Qualys
QLYS
$6.11B
| $7.25M | 0.13% |
86,912
-8,296
| -9% | -$688K |
|
218
Ciena
CIEN
$52.9B
| $7.23M | 0.13% |
169,443
+163,863
| +2,937% | +$6.24M |
|
219
Medpace
MEDP
$17.1B
| $7.22M | 0.13% |
85,935
-23,424
| -21% | -$1.81M |
|
220
Amphenol
APH
$191B
| $7.2M | 0.13% |
266,036
-247,200
| -48% | -$6.31M |
|
221
Lumen
LUMN
$5.89B
| $7.07M | 0.13% |
535,471
-618,369
| -54% | -$8.29M |
|
222
SPS Commerce
SPSC
$2.94B
| $7.03M | 0.13% |
126,837
-12,122
| -9% | -$645K |
|
223
Range Resources
RRC
$9.58B
| $6.99M | 0.13% |
1,441,614
+381,480
| +36% | +$1.54M |
|
224
SS&C Technologies
SSNC
$19.6B
| $6.99M | 0.13% |
113,868
+100,842
| +774% | +$5.65M |
|
225
Edwards Lifesciences
EW
$52.1B
| $6.98M | 0.13% |
+89,811
| New | +$7.01M |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.